Company intelligence / Profile preview

FGF Therapeutics

Ownership: Private
Development stage: Other

Overview

FGF Therapeutics is a biotechnology company focused on developing therapeutic applications of Fibroblast Growth Factors (FGFs) for regenerative medicine and aesthetic indications. The company's primary focus is on the development of stabilized recombinant FGF proteins to address conditions such as hair loss (alopecia) and chronic wound healing. By leveraging the potent mitogenic and angiogenic properties of the FGF family, the company aims to create effective treatments for tissue repair and dermatological health. Their lead research involves optimizing the delivery and stability of FGF2 to stimulate hair follicle regeneration and skin rejuvenation.

Therapeutic areas: Dermatology
Modalities: Recombinant proteinBiologic
Industry: Biotech

Beyond the preview

Go deeper on FGF Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FGF Therapeutics.

Explore the full profile